Optimizing the use of tumour necrosis factor inhibitors in Crohn's disease: a practical approach.

Drugs
Maria Josefina EtcheversElena Ricart

Abstract

Crohn's disease is a chronic, disabling, inflammatory condition of the gastrointestinal tract that has a segmental distribution and can affect the entire gastrointestinal tract. Treatment of patients with Crohn's disease represents a difficult challenge to physicians. Conventional therapy includes corticosteroids and immunosuppressants. Corticosteroids are highly effective for inducing response and remission, but the results in the long-term are disappointing and are associated with serious adverse events. Immunosuppressants are effective, but have a slow onset of action and are associated with intolerance and adverse events. In the last decade, as a result of a better understanding of the immunopathology of inflammatory bowel disease, novel therapeutic agents have been developed to target crucial components of the inflammatory cascade. Tumour necrosis factor (TNF) inhibitors (infliximab, adalimumab and certolizumab pegol) offer an effective alternative therapy, and are widely used in clinical practice for the management of Crohn's disease and ulcerative colitis. This article focuses on the latest evidence-based data on clinical effectiveness, mucosal healing, immunogenicity, dose optimization for induction and maintenance of r...Continue Reading

References

Apr 1, 1990·Ceskoslovenská pediatrie·A Kolek
May 1, 1980·The New England Journal of Medicine·D H PresentB S Pasternack
Apr 1, 1997·Gut·S J Van Deventer
May 6, 1999·The New England Journal of Medicine·D H PresentS J van Deventer
Oct 28, 1999·Gastrointestinal Endoscopy·G D'HaensP Rutgeerts
Jun 6, 2002·Lancet·Stephen B HanauerUNKNOWN ACCENT I Study Group
Aug 9, 2002·The New England Journal of Medicine·Daniel K Podolsky
Feb 14, 2003·The New England Journal of Medicine·Filip BaertPaul Rutgeerts
Sep 2, 2003·Gastroenterology·Nazia SelznerPierre-Alain Clavien
Feb 6, 2004·Gastroenterology·Paul RutgeertsStephen B Hanauer
Feb 27, 2004·The New England Journal of Medicine·Bruce E SandsSander J van Deventer
Jun 30, 2004·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Stephen B HanauerPaul Rutgeerts
Jun 9, 2005·Gastroenterology·Marc LémannUNKNOWN Groupe D'Etude Thérapeutique des Affections Inflammatoires du Tube Digestif
Feb 17, 2006·Gut·S P L TravisUNKNOWN European Crohn's and Colitis Organisation
Mar 15, 2006·Gastroenterology·Laurent BeaugerieJacques Cosnes
Apr 19, 2006·Gastroenterology·Marc LémannUNKNOWN Groupe d'Etude Therapeutique des Affections Inflammatoires du Tube Digestif (GETAID)
Aug 26, 2006·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Elana A MaserGordon R Greenberg
Jan 16, 2007·The American Journal of Gastroenterology·Claudio PapiLucio Capurso
May 2, 2007·Annals of Internal Medicine·William J SandbornPaul F Pollack
May 8, 2007·Inflammatory Bowel Diseases·Miguel RegueiroScott Plevy
Jul 20, 2007·The New England Journal of Medicine·William J SandbornUNKNOWN PRECISE 1 Study Investigators
Jul 20, 2007·The New England Journal of Medicine·Stefan SchreiberUNKNOWN PRECISE 2 Study Investigators
Aug 8, 2007·Gastroenterology·Kathrine Frey FrøslieUNKNOWN IBSEN Group
Feb 26, 2008·Gastroenterology·Murat TorunerLaurence J Egan
Jun 19, 2008·Gut·Z Liao, Z-S Li
Nov 28, 2008·Alimentary Pharmacology & Therapeutics·A OussalahL Peyrin-Biroulet

❮ Previous
Next ❯

Citations

Apr 16, 2013·Inflammatory Bowel Diseases·Yi-Lin ChiuSusan K Paulson
Aug 26, 2014·Pharmacological Reports : PR·Grzegorz CessakEwa Bałkowiec-Iskra
Feb 5, 2013·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Christine KestensUNKNOWN Dutch Initiative on Crohn and Colitis (ICC)
Oct 19, 2010·Gastroenterology Clinics of North America·Thomas W Lee, Richard N Fedorak
May 6, 2011·The American Journal of Medicine·Arthur F KavanaughStephen B Hanauer

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Inflammatory Bowel Diseases
Miguel RegueiroScott Plevy
Expert Review of Gastroenterology & Hepatology
Ming Valerie LinGary R Lichtenstein
The New England Journal of Medicine
W J SandbornPRECISE 1 Study Investigators
© 2021 Meta ULC. All rights reserved